疼痛管理治療薬市場：治療薬別、適応症別、流通チャネル別-2025-2030年の世界予測

疼痛管理治療薬市場は、2023年に826億6,000万米ドルと評価され、2024年には865億1,000万米ドルに達すると予測され、CAGR 4.74％で成長し、2030年には1,143億5,000万米ドルに達すると予測されています。

疼痛管理治療薬市場には、オピオイド、非ステロイド性抗炎症薬（NSAIDs）、抗けいれん薬、抗うつ薬など、慢性および急性の痛みを緩和するためのさまざまな治療薬が含まれます。この市場を牽引しているのは、慢性疾患の蔓延、高齢化、外科手術の増加に対応する必要性であり、効果的な疼痛管理ソリューションへの需要が高まっています。主な用途は、関節炎、がん、神経障害性疼痛、術後疼痛などの治療で、ヘルスケア施設、在宅介護環境、リハビリセンターなどに対応しています。市場の最終用途には、病院、外来手術センター、疼痛管理専門クリニックなどが含まれ、医療従事者や生活の質の向上を目指す患者がこれらの治療薬を積極的に利用しています。

市場成長は、技術の進歩、患者意識の高まり、疼痛管理プログラムに対する政府の支援策などの要因に大きく影響されます。さらに、非オピオイド鎮痛薬や生物製剤の開発は、中毒性のオピオイドへの依存を減らし、アンメット・メディカル・ニーズに対応することを切望する利害関係者に潜在的な機会を提供します。しかし、厳しい規制要件、鎮痛薬に関連する副作用、偽造薬の出現などが、顕著な制約と課題となっています。刻々と迫るオピオイド危機も市場の複雑さに拍車をかけており、その結果、市場の安定と成長を妨げる可能性のある監視の強化や散発的な政策転換が起こっています。

革新的なビジネスチャンスは、精密医療アプローチの研究開発、個別化疼痛管理ソリューション、治療効果と患者のアドヒアランスを高めるための患者モニタリングや遠隔医療などのデジタルヘルス技術の統合にあります。市場は成熟しているが、新たな健康動向や技術の進歩に適応しながら進化しています。今後の最良の戦略としては、費用対効果の高い非オピオイド性疼痛治療薬の開発、疼痛管理における予測分析のための人工知能の活用、より安全で効果的な疼痛管理を実践するための患者教育イニシアチブの拡大に注力することが挙げられます。

市場力学：急速に進化する疼痛管理治療薬市場の主要市場インサイトを公開

疼痛管理治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の増加
  • 老年人口の増加
  • 事故やスポーツによる怪我の増加
• 市場抑制要因
  • 疼痛緩和器具などの代替品の存在
  • 完全な疼痛管理ソリューションの不在
• 市場機会
  • 新興国におけるヘルスケアインフラの改善
  • 疼痛治療薬の継続的な研究開発
• 市場の課題
  • 鎮静や吐き気など、鎮痛剤の副作用リスク

ポーターの5つの力：疼痛管理治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：疼痛管理治療薬市場における外部からの影響の把握

外部マクロ環境要因は、疼痛管理治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析疼痛管理治療薬市場における競合情勢の把握

疼痛管理治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス疼痛管理治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、疼痛管理治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨疼痛管理治療薬市場における成功への道筋を描く

疼痛管理治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の発症率の上昇
    • 高齢化人口の増加
    • 事故やスポーツによる傷害の発生率の増加
  • 抑制要因
    • 鎮痛器具などの代替品の入手可能性
    • 完璧な疼痛管理ソリューションの欠如
  • 機会
    • 新興国におけるヘルスケアインフラの改善
    • 疼痛治療における継続的な研究開発
  • 課題
    • 鎮静や吐き気などの鎮痛剤の副作用のリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 疼痛管理治療薬市場セラピューティクス

• 麻酔薬
• 抗けいれん薬
• 抗うつ薬
• 片頭痛治療薬
• 非麻薬性鎮痛剤
• 非ステロイド性抗炎症薬
• オピオイド

第7章 疼痛管理治療薬市場適応症別

• 関節炎の痛み
• がんの痛み
• 慢性腰痛
• 線維筋痛症
• 片頭痛
• 神経障害性疼痛
• 術後の痛み

第8章 疼痛管理治療薬市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 南北アメリカの疼痛管理治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の疼痛管理治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの疼痛管理治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AstraZeneca
• Eli Lilly & Company
• Endo Pharmaceuticals Inc.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson Services
• Mallinckrodt Pharmaceuticals Company
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Purdue Pharma L.P.
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. PAIN MANAGEMENT THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PAIN MANAGEMENT THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PAIN MANAGEMENT THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PAIN MANAGEMENT THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PAIN MANAGEMENT THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIMIGRAINE AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-NARCOTIC ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ARTHRITIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. CHINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 55. CHINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. INDIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 58. INDIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. MALAYSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. PHILIPPINES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. SINGAPORE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. SOUTH KOREA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. TAIWAN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. THAILAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. VIETNAM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. DENMARK PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. EGYPT PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. FINLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. FRANCE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. GERMANY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. ISRAEL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. ITALY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 110. ITALY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. ITALY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. NETHERLANDS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. NIGERIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. NORWAY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. POLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 122. POLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. POLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. QATAR PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 125. QATAR PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. QATAR PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. RUSSIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SAUDI ARABIA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. SPAIN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. SWEDEN PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. SWITZERLAND PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. TURKEY PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. UNITED ARAB EMIRATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. PAIN MANAGEMENT THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 155. PAIN MANAGEMENT THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Pain Management Therapeutics Market was valued at USD 82.66 billion in 2023, expected to reach USD 86.51 billion in 2024, and is projected to grow at a CAGR of 4.74%, to USD 114.35 billion by 2030.

The scope of the Pain Management Therapeutics market encompasses a variety of treatments designed to alleviate chronic and acute pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and antidepressants. This market is driven by the necessity to address the growing prevalence of chronic diseases, an aging population, and increasing surgical procedures which heighten the demand for effective pain management solutions. The primary applications involve treatments for conditions such as arthritis, cancer, neuropathic pain, and post-operative pain, catering to healthcare facilities, homecare settings, and rehabilitation centers. The market's end-use scope prominently includes hospitals, ambulatory surgical centers, and specialized pain management clinics, with robust utilization of these therapeutics by healthcare professionals and patients aiming for improved quality of life.

Market growth is significantly influenced by factors such as technological advancements, increasing patient awareness, and supportive government initiatives for pain management programs. Additionally, the development of non-opioid pain medication and biologics presents potential opportunities for stakeholders eager to reduce reliance on addictive opioids and address unmet medical needs. However, stringent regulatory requirements, side effects related to pain medications, and the emergence of counterfeit drugs pose notable constraints and challenges. The ever-looming opioid crisis also feeds into the market's complexities, resulting in heightened scrutiny and sporadic policy shifts that could hinder market stability and growth.

Innovative opportunities lie in the research and development of precision medicine approaches, personalized pain management solutions, and the integration of digital health technologies, such as patient monitoring and telehealth, to enhance treatment efficacy and patient adherence. The market is mature, yet evolving as it adapts to new health trends and technological advancements. The best future strategies involve focusing on developing cost-effective non-opioid pain therapeutics, leveraging artificial intelligence for predictive analytics in pain management, and expanding patient education initiatives for safer and more effective pain management practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pain Management Therapeutics Market

The Pain Management Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in incidences of chronic diseases
  • Growing geriatric population
  • Increase in incidence of accidental and sports injuries
• Market Restraints
  • Availability of substitutes such as pain relief devices
  • Absence of a perfect pain management solution
• Market Opportunities
  • Improving healthcare infrastructure in emerging countries
  • Ongoing research and development in the pain therapeutics
• Market Challenges
  • Risk of side effects of pain medications such as sedation and nausea

Porter's Five Forces: A Strategic Tool for Navigating the Pain Management Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pain Management Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pain Management Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pain Management Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pain Management Therapeutics Market

A detailed market share analysis in the Pain Management Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pain Management Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pain Management Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pain Management Therapeutics Market

A strategic analysis of the Pain Management Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pain Management Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca, Eli Lilly & Company, Endo Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson Services, Mallinckrodt Pharmaceuticals Company, Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Pain Management Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapeutics, market is studied across Anesthetics, Anticonvulsants, Antidepressants, Antimigraine Agents, Non-Narcotic Analgesics, Non-Steroidal Anti-inflammatory Drugs, and Opioids.
• Based on Indication, market is studied across Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, Migraine, Neuropathic Pain, and Post-Operative Pain.
• Based on Distribution Channel, market is studied across Hospitals Pharmacy, Online Pharmacy, and Retail Pharmacy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in incidences of chronic diseases
    • 5.1.1.2. Growing geriatric population
    • 5.1.1.3. Increase in incidence of accidental and sports injuries
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of substitutes such as pain relief devices
    • 5.1.2.2. Absence of a perfect pain management solution
  • 5.1.3. Opportunities
    • 5.1.3.1. Improving healthcare infrastructure in emerging countries
    • 5.1.3.2. Ongoing research and development in the pain therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of side effects of pain medications such as sedation and nausea
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pain Management Therapeutics Market, by Therapeutics

• 6.1. Introduction
• 6.2. Anesthetics
• 6.3. Anticonvulsants
• 6.4. Antidepressants
• 6.5. Antimigraine Agents
• 6.6. Non-Narcotic Analgesics
• 6.7. Non-Steroidal Anti-inflammatory Drugs
• 6.8. Opioids

7. Pain Management Therapeutics Market, by Indication

• 7.1. Introduction
• 7.2. Arthritic Pain
• 7.3. Cancer Pain
• 7.4. Chronic Back Pain
• 7.5. Fibromyalgia
• 7.6. Migraine
• 7.7. Neuropathic Pain
• 7.8. Post-Operative Pain

8. Pain Management Therapeutics Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospitals Pharmacy
• 8.3. Online Pharmacy
• 8.4. Retail Pharmacy

9. Americas Pain Management Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pain Management Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pain Management Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca
• 3. Eli Lilly & Company
• 4. Endo Pharmaceuticals Inc.
• 5. F. Hoffmann La Roche Ltd.
• 6. GlaxoSmithKline Plc
• 7. Johnson & Johnson Services
• 8. Mallinckrodt Pharmaceuticals Company
• 9. Merck & Co. Inc.
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Purdue Pharma L.P.
• 13. Teva Pharmaceutical Industries Ltd.